Abstract
Background
Circular RNAs (circRNAs), new members of the noncoding RNA family, have been reported to participate in various pathological conditions, especially cancer. Pancreatic ductal adenocarcinoma (PDAC), as one of the most aggressive human solid tumors, is still with a low surgical cure rate. Exploring the role of circRNAs in PDAC is meaningful, and may offer a new therapeutic approach for PDAC.
Methods and Results
Competing endogenous RNA (ceRNA) microarray revealed that circ-0047078 was highly expressed in pancreatic ductal adenocarcinoma (PDAC) tissues compared with adjacent normal tissues, and the differential expression was further confirmed by PCR in both tissues and cell lines. Cell functional assays including cell counting kit-8 (CCK-8) assay, transwell invasion assay, flow cytometry and caspase activity assay demonstrated that circ-0047078 was positively correlated with the proliferation and invasion but negatively correlated with the apoptosis of CFPAC-1 cells. Circ-0047078 knockdown led to miR-11181, CXCL12 and MCAM downregulation and RGS16 upregulation, and the effect of circ-0047078 knockdown on CFPAC-1 cell behavior change can be reversed by miR-11181 mimic. Moreover, clinicopathological analysis indicated that circ-0047078 expression level was positively correlated with lymphatic metastasis and perineural invasion. In addition, knockdown of Chemokine (C-X-C motif) Ligand 12 (CXCL12) alone decreased proliferation, invasion, but increased apoptosis of CFPAC-1 cells, and raised the activity of caspase-3, caspase-8 and caspase-9 activity. Knockdown of Melanoma Cell Adhesion Molecule (MCAM) alone decreased invasion and increased apoptosis of CFPAC-1 cells, and both caspase-3 and caspase-9 activity increased, but no obvious change observed on caspase-8, and also no significant effect on CFPAC-1 cells proliferation. Knockdown of Regulator of G-protein signaling 16 (RGS16) alone increased invasion of CFPAC-1 cells, but had no significant effect on proliferation and apoptosis, of course, no obvious change on the activity of caspase-3, caspase-8 and caspase-9 had been observed.
Conclusions
In conclusion, circ-0047078 plays a role in promoting PDAC via miR-11181 and then via CXCL12, MCAM and RGS16. Circ-0047078 may serve as a promising novel therapeutic target for PDAC patients.
Similar content being viewed by others
References
Ferlay J, Colombet M, Soerjomataram I et al (2021) Cancer statistics for the year 2020: an overview. Int J Cancer 149:778–789
Schizas D, Charalampakis N, Kole C et al (2020) Immunotherapy for pancreatic cancer: a 2020 update. Cancer Treat Rev 86:102016
Roth MT, Cardin DB, Berlin JD (2020) Recent advances in the treatment of pancreatic cancer. F1000Res 9:131
Luo W, Tao J, Zheng L, Zhang T (2020) Current epidemiology of pancreatic cancer: challenges and opportunities. Chin J Cancer Res 32(6):705–719
Pereira SP, Oldfield L, Ney A et al (2020) Early detection of pancreatic cancer. Lancet Gastroenterol Hepatol 5(7):698–710
Zhang HD, Jiang LH, Sun DW, Hou JC, Ji ZL (2018) CircRNA: a novel type of biomarker for cancer. Breast Cancer 25(1):1–7
Kristensen LS, Jakobsen T, Hager H, Kjems J (2022) The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol 19(3):188–206
Goodall GJ, Wickramasinghe VO (2021) RNA in cancer. Nat Rev Cancer 21(1):22–36
Wong CH, Lou UK, Li Y et al (2020) CircFOXK2 promotes growth and metastasis of pancreatic ductal adenocarcinoma by complexing with RNA-binding proteins and sponging MiR-942. Cancer Res 80(11):2138–2149
Ye Z, Zhu Z, Xie J et al (2020) Hsa_circ_0000069 knockdown inhibits tumorigenesis and exosomes with downregulated hsa_circ_0000069 suppress malignant transformation via inhibition of STIL in pancreatic cancer. Int J Nanomed 15:9859–9873
Zhang X, Tan P, Zhuang Y, Du L (2020) hsa_circRNA_001587 upregulates SLC4A4 expression to inhibit migration, invasion, and angiogenesis of pancreatic cancer cells via binding to microRNA-223. Am J Physiol Gastrointest Liver Physiol 319(6):G703–G717
Dokanehiifard S, Soltani BM (2018) Hsa-miR-11181 regulates Wnt signaling pathway through targeting of APC2 transcripts in SW480 cell line. Gene 641:297–302
Sleightholm RL, Neilsen BK, Li J et al (2017) Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy. Pharmacol Ther 179:158–170
Layeghi-Ghalehsoukhteh S, Pal Choudhuri S, Ocal O et al (2020) Concerted cell and in vivo screen for pancreatic ductal adenocarcinoma (PDA) chemotherapeutics. Sci Rep 10(1):20662
von Burstin J, Bachhuber F, Paul M, Schmid RM, Rustgi AK (2017) The TALE homeodomain transcription factor MEIS1 activates the pro-metastatic melanoma cell adhesion molecule Mcam to promote migration of pancreatic cancer cells. Mol Carcinog 56(3):936–944
Sanger HL, Klotz G, Riesner D, Gross HJ, Kleinschmidt AK (1976) Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci USA 73(11):3852–3856
Salzman J, Gawad C, Wang PL, Lacayo N, Brown PO (2012) Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS ONE 7(2):e30733
Hansen TB, Jensen TI, Clausen BH et al (2013) Natural RNA circles function as efficient microRNA sponges. Nature 495(7441):384–388
Jeck WR, Sorrentino JA, Wang K et al (2013) Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 19(2):141–157
Memczak S, Jens M, Elefsinioti A et al (2013) Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495(7441):333–338
Zhang Y, Yu F, Bao S, Sun J (2019) Systematic characterization of circular RNA-associated CeRNA network identified novel circRNA biomarkers in Alzheimer’s disease. Front Bioeng Biotechnol 7:222
Prestes PR, Maier MC, Woods BA, Charchar FJ (2020) A guide to the short, long and circular RNAs in hypertension and cardiovascular disease. Int J Mol Sci 21(10):3666
Liu S, Wang C, Bai J et al (2021) Involvement of circRNA_0007059 in the regulation of postmenopausal osteoporosis by promoting the microRNA-378/BMP-2 axis. Cell Biol Int 45(2):447–455
Ju HQ, Zhao Q, Wang F et al (2019) A circRNA signature predicts postoperative recurrence in stage II/III colon cancer. EMBO Mol Med 11(10):e10168
Zheng X, Huang M, Xing L et al (2020) The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer. Mol Cancer 19(1):73
Xu H, Sun Y, You B, Huang CP, Ye D, Chang C (2020) Androgen receptor reverses the oncometabolite R-2-hydroxyglutarate-induced prostate cancer cell invasion via suppressing the circRNA-51217/miRNA-646/TGFβ1/p-Smad2/3 signaling. Cancer Lett 472:151–164
Huang XY, Huang ZL, Huang J et al (2020) Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis. J Exp Clin Cancer Res 39(1):20
Kong Y, Li Y, Luo Y et al (2020) circNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p/PIK3R1/VEGF-C axis in pancreatic cancer. Mol Cancer 19(1):82
Li X, Yang L, Chen LL (2018) The biogenesis, functions, and challenges of circular RNAs. Mol Cell 71(3):428–442
He AT, Liu J, Li F, Yang BB (2021) Targeting circular RNAs as a therapeutic approach: current strategies and challenges. Signal Transduct Target Ther 6(1):185
Santer L, Bär C, Thum T (2019) Circular RNAs: a novel class of functional RNA molecules with a therapeutic perspective. Mol Ther 27(8):1350–1363
Acknowledgements
This project was supported by grants from the Daping Hospital, Army Medical University (2019CXJSA003) to Ping Chen.
Funding
This project was supported by grants from the Daping Hospital, Army Medical University (2019CXJSA003) to Ping Chen.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation was performed by Yuzhou Wang, Ping Chen and Yan Jiang. Data collection and analysis were performed by Yuzhou Wang, Hangwei Fu and Bo Zhou. The first draft of the manuscript was written by Yuzhou Wang. And all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Army Medical Center of PLA.
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wang, Y., Fu, H., Jiang, Y. et al. Novel circularRNA circ-0047078 promotes pancreatic ductal adenocarcinoma progression through mircoRNA miR-11181— Chemokine (C-X-C motif) Ligand 12/Melanoma Cell Adhesion Molecule/Regulator of G-protein signaling 16 pathway. Mol Biol Rep 49, 8761–8775 (2022). https://doi.org/10.1007/s11033-022-07723-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-022-07723-4